Board of Directors
Executive Directors
-
Mr. Wang Chuang (Chairman, chief executive officer and executive director)
Mr. Wang Chuang, joined the Group on 18 October 2019 as the Chairman, chief executive officer and executive director of the Company. Mr. Wang has been primarily responsible for overall operation and management, strategic planning and business development.
Mr. Wang was a senior executive of Changzhou Meichen Company Limited* (常州美晨有限公司), Wuxi Shencai Company Limited* (無錫神采有限公司) and Jiangsu Zhenai Company Limited* (江蘇真愛有限公 司) between 2002 and 2008.
He was the chairman of Hong Kong Bomei (China) Company Limited* (香港博美中國分公司) between 2008 and 2019. From 2015 to 2019, he acted as the chief executive officer of Changzhou XingKong Medical Clinic Co., Ltd.* (常州市星空醫療美容門診有限公司) and the chairman of Jiangsu XingKong Health Management Consulting Co., Ltd.* (江蘇星空健康管理諮詢有限公司). He is a committee member of the Organization Committee of the 2017 Boao Forum for Biomedical Sciences *(2017博鰲生物醫學論壇組織委員會) and the founder of Bomei Angel Charity Fund* (博美天使慈善基金). Mr. Wang is the president of the Chamber of Commerce of Changzhou Lishui* (常州溧水商會會長) and the vice president of the China’s National Alliance for Maternal and Child Health Development* (全國婦幼健康促進發展聯盟).
Mr. Wang Chuang was accredited as a grade 1 health management professional and a psychological consultant by the Hubei Provincial Department of Human Resources and Social Security of China and the Ministry of Human Resources and Social Security of China in May 2016 and March 2019.
Independent Non-executive Directors
-
Dr. Liu Ming
Dr. Liu Ming, joined the Group and was appointed as an independent non-executive Director on 30 December 2021. Dr. Liu graduated from the West China School of Medicine, West China Hospital of Sichuan University in 1991 with a Doctor of Medicine degree. He served in the Department of Otorhinolaryngology, Shenzhen People’s Hospital (Level A) (the “Hospital”) from 1991 to 2016 and served as the head of the Department of Otorhinolaryngology of the Hospital since 1998. He has been served as Deputy Director of the Hospital since 2006. He is currently a special expert of the Hospital in the Department of Otolaryngology. He has more than 25 years of medical clinical and hospital management experience.
Dr. Liu has been serving as executive director and a manager of Shenzhen Jianda Information Technology Limited since 2018, which is mainly engaged in the development and application of sleep breathing monitoring products. Dr. Liu has previously served as a general manager of a subsidiary of the Company since May 2018 and resigned from that position in August 2019.
Dr. Liu holds several community positions including the Standing Director of the Seventh Committee of the Shenzhen Medical Association, the Standing Committee member of the China International Association for the Promotion of Health Care, and the Standing Committee member of the Sleep Medicine Branch of the Guangdong Association of Rehabilitation Medicine.
-
Ms. Huo Chunyu
Ms. Huo Chunyu, joined the Group and was appointed as an independent non-executive Director of the Company on 30 January 2020. Ms. Huo obtained a bachelor degree from Hebei University of Economics and Business (河北經貿大學). She has over 20 years of commercial and professional experience with companies including the Industrial and Commercial Bank of China Hebei Branch (中國工商銀行河北省分行), Shijiazhuang Haowei Optoelectronic Thin Film Technology Co., Ltd (石家莊豪 威光電子薄膜技術有限公司) and Hebei Youyuan Certified Public Accountants (河北有源會計師事務所). Since September 2012, she has been a Partner of Ruihua Certified Public Accountants (瑞華會計師事務所).
-
Mr. Leung Man Fai
Mr. Leung Man Fai, joined the Group and was appointed as an independent non-executive Director on 30 December 2021. Mr. Leung graduated from Manchester Polytechnic in the United Kingdom with a degree of Bachelor of Arts in Accounting and Finance awarded by the Council for National Academic Awards of the United Kingdom in July 1988. He also obtained a degree of Master of Commerce in Accounting from the University of New South Wales in May 1990.
Mr. Leung has been a member of the HKICPA since June 1991 and has approximately 30 years of working experience in accounting, corporate finance and corporate management.
Mr. Leung is a company secretary of MediNet Group Limited (stock code: 8161), a company listed on the GEM Board of the Stock Exchange since November 2015 and he was a company secretary of Creative Enterprise Holdings Limited (stock code: 3992) from May 2018 to September 2021, which has been delisted from the Stock Exchange from October 2021. Mr. Leung has been an independent non-executive Director of Vital Innovations Holdings Limited (stock code: 6133), a company listed on the Main Board of the Stock Exchange since 30 December 2020.
Senior Management
-
Mr. Wong Po Tin (Company secretary and the Authorised Representative)
Mr. Wong, is currently the chief financial officer of the Company. He is a qualified accountant and is a member of Hong Kong Institute of Certified Public Accountants, a fellow member of the Association of Chartered Certified Accountants, a Chartered Secretary, a Chartered Governance Professional and associate member of each of The Hong Kong Chartered Governance Institute (the “HKCGI”), and The Chartered Governance Institute. Mr. Wong obtained a Master of Science in Corporate Governance and Compliance from Hong Kong Baptist University. Mr. Wong was the chief financial officer and company secretary of Huiyin Holdings Group Limited (a company listed on the Main Board until 19 August 2022 (stock code: 1178)) for the period from 1 March 2021 to 26 August 2022. He also holds a money lender license under the Money Lenders Ordinance (Cap. 163 of the Laws of Hong Kong) for China Enterprise Finance Company Limited, a wholly-owned subsidiary of King Stone Energy Group Limited (a company listed on the Main Board (stock code: 663)) and directorship in various private companies.